S Munkvad

Author PubWeight™ 6.03^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study.	J Am Coll Cardiol	1991	1.39
2	Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium.	J Intern Med	1990	0.80
3	Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled study.	Scand J Clin Lab Invest	1991	0.78
4	Depressed plasma fibrinolytic activity in a group of patients with connective tissue diseases.	Scand J Rheumatol	1989	0.78
5	Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma.	Clin Chem	1990	0.77
6	Interleukin-1 and tumor necrosis factor-alpha in plasma of patients with acute ischemic heart disease who undergo thrombolytic therapy: a randomized, placebo-controlled study.	Lymphokine Cytokine Res	1991	0.77
7	A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction.	Eur Heart J	1990	0.76
8	Plasma HMW fibrinogen in patients with ischaemic heart disease.	Scand J Clin Lab Invest	1990	0.75
9	Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasma.	Clin Chem	1990	0.75
10	Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapy.	J Am Coll Cardiol	1991	0.75